Osaic Holdings
AVIR icon

Osaic Holdings’s Atea Pharmaceuticals AVIR Stock Holding History

Osaic Holdings’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.51K Sell
1,025
-300
-23% -$1.38K ﹤0.01% 6636
2025
Q4 		$4.73K Hold
1,325
– – ﹤0.01% 6736
2025
Q3 		$3.87K Sell
1,325
-5
-0.4% -$17 ﹤0.01% 6888
2025
Q2 		$4.79K Sell
1,330
-45
-3% -$134 ﹤0.01% 6563
2025
Q1 		$4.11K Sell
1,375
-2,925
-68% -$9.13K ﹤0.01% 6274
2024
Q4 		$14.4K Sell
4,300
-533
-11% -$1.77K ﹤0.01% 5559
2024
Q3 		$16.2K Buy
4,833
+1,033
+27% +$3.75K ﹤0.01% 5503
2024
Q2 		$12.6K Sell
3,800
-3,526
-48% -$13.1K ﹤0.01% 5641
2024
Q1 		$29.6K Hold
7,326
– – ﹤0.01% 5107
2023
Q4 		$22.3K Sell
7,326
-1,825
-20% -$5.53K ﹤0.01% 5440
2023
Q3 		$27.5K Buy
9,151
+1,997
+28% +$6.79K ﹤0.01% 5379
2023
Q2 		$26.8K Buy
7,154
+3,453
+93% +$12.9K ﹤0.01% 5375
2023
Q1 		$12.4K Sell
3,701
-70
-2% -$284 ﹤0.01% 5849
2022
Q4 		$19K Sell
3,771
-421
-10% -$2.13K ﹤0.01% 5596
2022
Q3 		$24K Hold
4,192
– – ﹤0.01% 5430
2022
Q2 		$29K Buy
4,192
+122
+3% +$833 ﹤0.01% 5352
2022
Q1 		$28K Buy
4,070
+1,794
+79% +$12.2K ﹤0.01% 5464
2021
Q4 		$20K Buy
2,276
+1,950
+598% +$30.4K ﹤0.01% 5780
2021
Q3 		$11K Buy
326
+150
+85% +$4.16K ﹤0.01% 6130
2021
Q2 		$4K Buy
+176
New +$5.29K ﹤0.01% 6456

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Osaic Holdings's AVIR Position: Q1 2026 in Review

Osaic Holdings reduced its Atea Pharmaceuticals (AVIR) stake by 23% in Q1 2026, selling an estimated $1.38K and leaving 1,025 shares worth $5.51K. The position accounts for ﹤0.01% of the portfolio, ranked #6636.

Osaic Holdings first reported a position in AVIR in Q2 2021 and has held it in 20 quarters since. The position peaked at $29.6K in Q1 2024. 127 funds tracked by Wall St. Rank hold AVIR as of Q1 2026.

  • Osaic Holdings held 1,025 shares of Atea Pharmaceuticals worth $5.51K as of Q1 2026.
  • Osaic Holdings sold 300 Atea Pharmaceuticals shares in Q1 2026, an estimated $1.38K.
  • Atea Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #6636 holding.
  • Osaic Holdings first reported a position in Atea Pharmaceuticals in Q2 2021 and has held it in 20 quarters since.
  • Osaic Holdings's Atea Pharmaceuticals position peaked at $29.6K in Q1 2024.
  • 127 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.